These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29428402)

  • 21. Patent fight sparks biological warfare in the drug industry.
    Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
    [No Abstract]   [Full Text] [Related]  

  • 22. Intellectual property. Challenges to India's pharmaceutical patent laws.
    Sampat BN; Shadlen KC; Amin TM
    Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
    [No Abstract]   [Full Text] [Related]  

  • 23. Intellectual property rights and challenges for development of affordable human papillomavirus, rotavirus and pneumococcal vaccines: Patent landscaping and perspectives of developing country vaccine manufacturers.
    Chandrasekharan S; Amin T; Kim J; Furrer E; Matterson AC; Schwalbe N; Nguyen A
    Vaccine; 2015 Nov; 33(46):6366-70. PubMed ID: 26368398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. India's patent ecosystem - encouraging strong patents or discouraging innovation?
    Harrison C
    Nat Rev Drug Discov; 2013 Oct; 12(10):732-3. PubMed ID: 24080690
    [No Abstract]   [Full Text] [Related]  

  • 25. Patent litigation in India continues to throw up new challenges.
    Reddy Thikkavarapu P
    Pharm Pat Anal; 2016 Jul; 5(4):211-6. PubMed ID: 27348790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Court dismisses Novartis challenge to Indian patent law.
    Mudur G
    BMJ; 2007 Aug; 335(7614):273. PubMed ID: 17690349
    [No Abstract]   [Full Text] [Related]  

  • 27. Patent watch.
    Harrison C
    Nat Rev Drug Discov; 2013 Jan; 12(1):14-5. PubMed ID: 23274462
    [No Abstract]   [Full Text] [Related]  

  • 28. Preliminary injunctions in generic and branded patent litigation.
    Cohen S; England P
    Expert Opin Ther Pat; 2013 Sep; 23(9):1083-6. PubMed ID: 23855903
    [No Abstract]   [Full Text] [Related]  

  • 29. How Barr managed to kill Eli Lilly's patent on Prozac.
    Pabst PL
    Tissue Eng; 2001 Dec; 7(6):843-4. PubMed ID: 11749739
    [No Abstract]   [Full Text] [Related]  

  • 30. Engineered in India--patent law 2.0.
    Kapczynski A
    N Engl J Med; 2013 Aug; 369(6):497-9. PubMed ID: 23862973
    [No Abstract]   [Full Text] [Related]  

  • 31. Patent battle lines drawn as sofosbuvir gains approval.
    Harrison C
    Nat Rev Drug Discov; 2014 Jan; 13(1):12. PubMed ID: 24378791
    [No Abstract]   [Full Text] [Related]  

  • 32. Patent portfolios for biotech inventions.
    Wang SJ
    Nat Biotechnol; 2013 Jun; 31(6):501-3. PubMed ID: 23752433
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug firms lose patent rights lawsuit against South Africa's government.
    Baleta A
    Lancet; 2001 Apr; 357(9265):1347. PubMed ID: 11343755
    [No Abstract]   [Full Text] [Related]  

  • 34. Engineered in India--patent law 2.0.
    Castellani JJ
    N Engl J Med; 2013 Nov; 369(22):2163. PubMed ID: 24283241
    [No Abstract]   [Full Text] [Related]  

  • 35. Supreme Court of India rejects Novartis’ cancer drug patent.
    Heseltine P
    Pharm Pat Anal; 2013 May; 2(3):299-300. PubMed ID: 24237056
    [No Abstract]   [Full Text] [Related]  

  • 36. Universal pneumococcal vaccination for India.
    Mathew JL
    Indian Pediatr; 2008 Feb; 45(2):160-1. PubMed ID: 18310801
    [No Abstract]   [Full Text] [Related]  

  • 37. India's new patent laws may still hurt generic drug supplies.
    Chatterjee P
    Lancet; 2005 Apr 16-22; 365(9468):1378. PubMed ID: 15841559
    [No Abstract]   [Full Text] [Related]  

  • 38. Will the refusal of patent protection for Glivec® discourage future pharmaceutical innovation in India?
    Albutt J
    Pharm Pat Anal; 2013 Jul; 2(4):439-41. PubMed ID: 24237119
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes to India's patent law may deny cheap drugs to millions.
    Mudur G
    BMJ; 2005 Mar; 330(7493):692. PubMed ID: 15790640
    [No Abstract]   [Full Text] [Related]  

  • 40. 18 months sliced off Celebrex's patent protection.
    Harrison C
    Nat Rev Drug Discov; 2014 May; 13(5):326. PubMed ID: 24781542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.